BMI1 and colorectal cancer: 2013), but there are no studies that have reported such effects in other cancer cells. Thus, the objective of this present study was to assess the selected compounds’ (CUR, BDMC, DMC) effect on BMI1 expression in DLD‐1 colorectal cancer cells. Previously we identified that curcumin showed a similar inhibitory effect on genetically dissimilar DLD‐1, LoVo, and HCT‐116 cancer cell lines (Montgomery et al. 2016).